347 related articles for article (PubMed ID: 18292574)
21. Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different Toll-like receptors independent of paracrine mediators.
Lehner MD; Morath S; Michelsen KS; Schumann RR; Hartung T
J Immunol; 2001 Apr; 166(8):5161-7. PubMed ID: 11290799
[TBL] [Abstract][Full Text] [Related]
22. Staphylococcal lipoteichoic acid inhibits delayed-type hypersensitivity reactions via the platelet-activating factor receptor.
Zhang Q; Mousdicas N; Yi Q; Al-Hassani M; Billings SD; Perkins SM; Howard KM; Ishii S; Shimizu T; Travers JB
J Clin Invest; 2005 Oct; 115(10):2855-61. PubMed ID: 16184199
[TBL] [Abstract][Full Text] [Related]
23. Role of lipoteichoic acid in the phagocyte response to group B streptococcus.
Henneke P; Morath S; Uematsu S; Weichert S; Pfitzenmaier M; Takeuchi O; Müller A; Poyart C; Akira S; Berner R; Teti G; Geyer A; Hartung T; Trieu-Cuot P; Kasper DL; Golenbock DT
J Immunol; 2005 May; 174(10):6449-55. PubMed ID: 15879147
[TBL] [Abstract][Full Text] [Related]
24. Pulmonary lipopolysaccharide (LPS)-binding protein inhibits the LPS-induced lung inflammation in vivo.
Knapp S; Florquin S; Golenbock DT; van der Poll T
J Immunol; 2006 Mar; 176(5):3189-95. PubMed ID: 16493079
[TBL] [Abstract][Full Text] [Related]
25. Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved.
Schröder NW; Morath S; Alexander C; Hamann L; Hartung T; Zähringer U; Göbel UB; Weber JR; Schumann RR
J Biol Chem; 2003 May; 278(18):15587-94. PubMed ID: 12594207
[TBL] [Abstract][Full Text] [Related]
26. Improved host defense against pneumococcal pneumonia in platelet-activating factor receptor-deficient mice.
Rijneveld AW; Weijer S; Florquin S; Speelman P; Shimizu T; Ishii S; van der Poll T
J Infect Dis; 2004 Feb; 189(4):711-6. PubMed ID: 14767826
[TBL] [Abstract][Full Text] [Related]
27. Lipoteichoic acid-induced nitric oxide production depends on the activation of platelet-activating factor receptor and Jak2.
Han SH; Kim JH; Seo HS; Martin MH; Chung GH; Michalek SM; Nahm MH
J Immunol; 2006 Jan; 176(1):573-9. PubMed ID: 16365452
[TBL] [Abstract][Full Text] [Related]
28. PAFR activation of NF-κB p65 or p105 precursor dictates pro- and anti-inflammatory responses during TLR activation in murine macrophages.
Ishizuka EK; Filgueiras LR; Rios FJ; Serezani CH; Jancar S
Sci Rep; 2016 Aug; 6():32092. PubMed ID: 27554194
[TBL] [Abstract][Full Text] [Related]
29. Cytokine induction by purified lipoteichoic acids from various bacterial species--role of LBP, sCD14, CD14 and failure to induce IL-12 and subsequent IFN-gamma release.
Hermann C; Spreitzer I; Schröder NW; Morath S; Lehner MD; Fischer W; Schütt C; Schumann RR; Hartung T
Eur J Immunol; 2002 Feb; 32(2):541-51. PubMed ID: 11828371
[TBL] [Abstract][Full Text] [Related]
30. Proinflammatory cytokine production in liver regeneration is Myd88-dependent, but independent of Cd14, Tlr2, and Tlr4.
Campbell JS; Riehle KJ; Brooling JT; Bauer RL; Mitchell C; Fausto N
J Immunol; 2006 Feb; 176(4):2522-8. PubMed ID: 16456013
[TBL] [Abstract][Full Text] [Related]
31. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2.
Schwandner R; Dziarski R; Wesche H; Rothe M; Kirschning CJ
J Biol Chem; 1999 Jun; 274(25):17406-9. PubMed ID: 10364168
[TBL] [Abstract][Full Text] [Related]
32. Distinct post-receptor alterations generate gene- and signal-selective adaptation and cross-adaptation of TLR4 and TLR2 in human leukocytes.
Li L; Jacinto R; Yoza B; McCall CE
J Endotoxin Res; 2003; 9(1):39-44. PubMed ID: 12691617
[TBL] [Abstract][Full Text] [Related]
33. Redundant Toll-like receptor signaling in the pulmonary host response to Pseudomonas aeruginosa.
Skerrett SJ; Wilson CB; Liggitt HD; Hajjar AM
Am J Physiol Lung Cell Mol Physiol; 2007 Jan; 292(1):L312-22. PubMed ID: 16936244
[TBL] [Abstract][Full Text] [Related]
34. Differential involvement of TLR2 and TLR4 in host survival during pulmonary infection with Chlamydia pneumoniae.
Rodriguez N; Wantia N; Fend F; Dürr S; Wagner H; Miethke T
Eur J Immunol; 2006 May; 36(5):1145-55. PubMed ID: 16609927
[TBL] [Abstract][Full Text] [Related]
35. Highly purified lipoteichoic acid activates neutrophil granulocytes and delays their spontaneous apoptosis via CD14 and TLR2.
Lotz S; Aga E; Wilde I; van Zandbergen G; Hartung T; Solbach W; Laskay T
J Leukoc Biol; 2004 Mar; 75(3):467-77. PubMed ID: 14673018
[TBL] [Abstract][Full Text] [Related]
36. Leukocyte adhesion molecule and chemokine production through lipoteichoic acid recognition by toll-like receptor 2 in cultured human lymphatic endothelium.
Sawa Y; Tsuruga E; Iwasawa K; Ishikawa H; Yoshida S
Cell Tissue Res; 2008 Aug; 333(2):237-52. PubMed ID: 18523807
[TBL] [Abstract][Full Text] [Related]
37. Internalization and coreceptor expression are critical for TLR2-mediated recognition of lipoteichoic acid in human peripheral blood.
Bunk S; Sigel S; Metzdorf D; Sharif O; Triantafilou K; Triantafilou M; Hartung T; Knapp S; von Aulock S
J Immunol; 2010 Sep; 185(6):3708-17. PubMed ID: 20713893
[TBL] [Abstract][Full Text] [Related]
38. Quantitation of endotoxin and lipoteichoic acid virulence using toll receptor reporter gene.
Huggins T; Haught JC; Xie S; Tansky CS; Klukowska M; Miner MC; White DJ
Am J Dent; 2016 Dec; 29(6):321-327. PubMed ID: 29178719
[TBL] [Abstract][Full Text] [Related]
39. Induction of TLR2 expression by inflammatory stimuli is required for endothelial cell responses to lipopeptides.
Satta N; Kruithof EK; Reber G; de Moerloose P
Mol Immunol; 2008 Nov; 46(1):145-57. PubMed ID: 18722665
[TBL] [Abstract][Full Text] [Related]
40. Decreased expression of Toll-like receptor 2 and 4 on macrophages in experimental severe acute pancreatitis.
Matsumura N; Takeyama Y; Ueda T; Yasuda T; Shinzeki M; Sawa H; Nakajima T; Kuroda Y
Kobe J Med Sci; 2007; 53(5):219-27. PubMed ID: 18204298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
